Germany's Merck in advanced talks to acquire US biotech firm SpringWorks
(Corrects third to last paragraph to say "the erosion from LOEs (loss of exclusivity)", not "from LOEs (levels of evidence)") ...
FiercePharma1d
UPDATE: Merck KGaA sets its sights on acquisition of Ogsiveo maker SpringWorks
As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...
Germany’s Merck in Talks to Buy SpringWorks Therapeutics
Germany’s Merck KGaA is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical ...
Big Pharma, Bigger Bargain: Why Merck Stock Is Too Cheap To Ignore (Upgrade)
Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...
Merck's struggles with HPV vaccine send stock to worst selloff in almost 17 years
Merck's stock tumbled 11.8% Tuesday, putting it on track for its biggest one-day selloff in almost 17 years, after the drug company's softer-than-expected guidance amid struggles for its HPV vaccine ...
Zawya14d
Diatech Pharmacogenetics expands collaboration with Merck
Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees work to make a positive difference to millions of people’s lives ...
BioSpace14d
Diatech Pharmacogenetics Expands Collaboration with Merck to Enhance Patient Access to Personalized Medicine in the Middle East and Africa
Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees work to make a positive difference to millions of people’s lives ...
Nasdaq15d
Merck Q4 Earnings Coming Up: Buy, Hold or Sell MRK Stock Now?
Earnings estimates for Merck for 2025 have declined from $9.57 to $9.44 per share over the past 30 days. The healthcare bellwether’s performance has been solid, with the company exceeding ...
pharmaphorum16d
Merck & Co to repurpose failed obesity drug for NASH
Merck & Co is to pay $10 million to Hanmi to repurpose an obesity drug discarded by Johnson & Johnson, into a therapy for the fatty liver disease known as NASH. Non-alcoholic steatohepatitis ...
imdb.com16d
Run Sweetheart Run Director Shana Feste Understands The Importance Of Art As Catharsis [Exclusive Interview]
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...
Yahoo Finance18d
Jim Cramer Says Merck & Co., Inc. (MRK) ‘Needs To Have China Be Less Of Our Enemy’
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks Jim Cramer recently discussed. In his latest appearance on CNBC's Squawk on the ...
Nasdaq19d
March 7th Options Now Available For Merck (MRK)
Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the March 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRK ...